Antiviral Flashcards

(77 cards)

1
Q

Oseltamivir, Zanamivir:
MOA
Clinical Use
Administration

A

Inhib Flu Neuraminidase–>decrease release of progeny virus (DOESN’T KILL VIRUS)

  1. Flu A&B treatment/prevention
    * given within 48hrs of Symptoms (F/myalgias)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acyclovir, famciclovir, valacyclovir (prodrug):
MOA
MOResistance

A

Guanosine Analogs
RXN: Guanine –> Guanine-P –> Guanine-PPP
1. monophosphorylation occurs via HSV/VZV thymidine kinase
2. Triphosphate formed by cellular enzymes
3. preferentially inhib viral DNA polymerase by chain termination

  • phophorylation will only take place in uninfected cells–> few adverse cells

Resistance: Mutated viral thymidine kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
Acyclovir, famciclovir, valacyclovir (prodrug):
Clinical use(3)
A

Acute/reactivation HSV, VZV, EBV (weak)

  1. HSV mucocutaneous/genital lesion
  2. HSV encephalitis
  3. Px: immunocompromised patients
  • NOT FOR LATENT FORMS OF HSV/VZV
  • Valacyclovir=prodrug–>better oral bioavailability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drug used to treat Herpes Zosters

A

famciclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Acyclovir, famciclovir, valacyclovir (prodrug):
Adverse
How to avoid adverse?

A
  1. obstructive crystalline nephropathy
  2. Acute Renal Failure
  • Make sure patient stays HYDRATED
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Ganciclovir, Valganciclovir (prodrug):
MOA
MOResistance

A

Guanosine analog
Guanosine Analogs
RXN: Guanine –> Guanine-P –> Guanine-PPP
1. monophosphorylation occurs via CMV viral kinase
2. Triphosphate formed by cellular enzymes
3. preferentially inhib viral DNA polymerase by chain termination

Resistance: mutated viral kinase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

CMV types of infections in immunocompromised (3)

A
  1. CMV colitis
  2. CMV retinitis
  3. CMV esophagitis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ganciclovir, Valganciclovir (prodrug):

Clinical Use

A
  1. CMV, esp in immunocompromised patients

2. Valganciclovir=prodrug–> better oral bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Ganciclovir, Valganciclovir (prodrug):
Adverse
Compare toxicity of ganciclovir w/ acyclovir

A
  1. Bone Marrow Suppression (leukopenia, neutropenia, thrombocytopenia)
  2. Renal tox

toxicity: ganciclovir > acyclovir

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
CMV details:
Histo
Latent in which cells
infections
transmission:
A

Histo: owl’s eye inclusions
* latent in mononuclear cells

  1. congenital infection (TORCH)
  2. Mono (monospot -)
  3. pneumonia
  4. retinitis

-congenital, transfusion/transplant, sex, saliva, urine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Foscarnet:
MOA
MOResistance

A

Pyrophosphate analog (“pyro’FOS’phate”)

  • ->binds pyrophosphate-binding site of enzyme
    1. viral DNA/RNA polymerase inhib
    2. HIV reverse transcriptase inhib
  • does not require any kinase activation

Resistance: Mutated DNA polymerase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Foscarnet:

Clinical use

A

2nd line for CMV/ HSV

  1. CMV retinitis in immunocomp. pt. when ganciclovir fails
  2. acyclovir-resistant HSV

*can be used when resistance develops to ganciclovir/acyclovir b/c Foscarnet doesn’t require any kinase activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Foscarnet:

Adverse

A
  1. Nephrotox –>electrolyte abn (+/- Ca+2, +/- Phosphate, hypokalemia, hypomagnesemia)
  2. seizures (from electrolyte imbalance)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Which B-lactam Abx can cause seizures?

A

Carbapenems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Drugs which induce seizures

A

“With seizures, I BItE my tongue”

  1. Isoniazid (B6 def)
  2. Buproprion
  3. Imipenem/cilastatin
  4. Enflurane
  5. Foscarnet(from nephrotox)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cidofovir:
MOA
Half-life?

A

inhib viral DNA polymerase
-DOESN’T REQUIRE VIRAL KINASE PHOSPHORYLATION

-long half-life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q
Cidofovir:
Clinical use (2)
A
  1. CMV retinits in immunocompromised patients

2. acyclovir-resistant HSV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Cidofovir:
Adverse
How to decrease toxicity?

A

Nephrotox

coadmin w/ Probenecid + IV saline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Compare Foscarnet vs. Cidofovir:
MOA
Clinical Use
Adverse

A

Foscarnet: inhib both RNA/DNA pol & HIV RT
Cidofovir: inhib only DNA pol

  • both second line only
  • both cause Nephrotox
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is HAART?
When does it begin
Describe regimen

A

“highly active antiretroviral therapy”

-often initiated at time of HIV diagnosis. Strongest indication for patients presenting with AIDS-defining illness, low CD4+ cell counts (

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

NRTIs:

Name (7)

A

Nucleoside RT inhib.

  1. Abacavir (ABC)
  2. Didanosine (ddl)
  3. Emtricitibine (FTC)
  4. LamiVUDINE (3TC)
  5. StaVUDINE (d4T)
  6. Tenofovir (TDF)
  7. ZidoVUDINE (ZDV)

“haVE U DINED (VUDINE) with my NUCLEAR (NUCLEOSIDE) family?”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

NRTIs:

MOA

A

Competitively inhib Nucleotide binding to RT and terminate the DNA chain (lack 3’OH group)

*Require Phosphorylation to be active!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Unique characteristic of Tenofovir

A

‘T’enofovir is a nucleo’T’ide–> doesn’t require phosphorylation to become active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

2 uses Zidovudine

A
  1. general prophylaxis

2. during pregnancy to decrease risk of fetal transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Who is Abacavir contraindicated in?
pt with HLA-B*5701 mutation
26
NRTIs: Adverse How to decrease/overcome toxicity
1. Bone Marrow suppression (reverse w/ G-CSF or EPO) 2. peripheral neuropathy 3. lactic acidosis (nucleosides) 4. anemia (ZDV) 5. pancreatitis (didanosine)
27
NNRTIs: | Name 3
Non-nucleoside RT inhib 1. Delavirdine 2. Efavirenz 3. Nevirapine
28
NNRTIs: | MOA
Bind Reverse Transcriptase at different site than NRTI | *don't require phosphorylation to be active
29
NNRTIs: | Common adverse for all?
1. Rash | 2. Hepatotox (Allman taught not to start this class unless CD4 count was significantly low)
30
NNRTIs: | Which causes vivid dreams and CNS symptoms?
Efaviren'Z' *efaviren'z' gives you cra'z'y 'zzz's'
31
NNRTIs: | which are contraindicated in pregnancy? (2)
1. Delavirdine | 2. Efavirenz
32
Protease Inhibitors: | Name (7)
"-navir" --> "NAVIR (never) TEASE a PROTEASE" 1. Atazanavir 2. Darunavir 3. Fosamprenavir 4. Indinavir 5. Lopinavir 6. Ritonavir 7. Saquinavir
33
Protease Inhibitors: | MOA
Assembly of virons depends on HIV-1 protease (pol gene), which cleaves the polypeptide products of HIV mRNA into their functional parts. -->prevent maturation of new viruses
34
Protease Inhibitors: which can boost the other drug concentrations? How?
Ritonavir | - inhib P450
35
``` Protease Inhibitors: common Adverse(3) ```
1. hyperglycemia -->DM 2. GI intolerance (N/D) 3. Lipodystrophy -->Cushing-like syndrome
36
Protease Inhibitors: | Which causes Nephropathy/hematuria/ kidney stones?
Indinavir
37
Protease Inhibitors: | DD interaction
Rifampin | -potent CYP inducer (which would decrease protease inhib. concentration)
38
Integrase Inhibitors: | Name (3)
"-TEGRAvir" 1. Raltegravir 2. Elvitegravir 3. Dolutegravir
39
Integrase Inhibitors: MOA Adverse (1)
-inhib HIV genome INTEGRATION into host chromosome by reversibly inhib HIV integrate Adverse: increase creatine kinase
40
Fusion Inhibitors: Name 2 Adverse
1. Enfuvirtide 2. Maraviroc -Skin Rxn at injection site
41
Fusion Inhibitors: | MOA Enfuvirtide
binds gp41 --> inhibiting viral entry | "'E'arly in # for 'FU'sion"
42
Fusion Inhibitors: | MOA 'M'araviroc
Binds CCR-5 on surface of 'M'onocytes/Tcells--> inhib interaction with gp120
43
Which antiviral/class?: | screen HLA-B*5701?
Abacavir (NRTI)
44
Which antiviral/class?: | BM suppression
NRTI | Zidovudine also causes anemia
45
Which antiviral/class?: | pancreatitis
Didanosine (NRTI)
46
Which antiviral/class?: | Peripheral neuropathy
NRTI
47
Which antiviral/class?: | rash
NNRTI
48
Which antiviral/class?: | Lactic Acidosis
NRTIs
49
Which antiviral/class?: | Liver tox
NNRTI
50
Which antiviral/class?: | viral booster
Ritonavir
51
Which antiviral/class?: | Nephrolithiasis
Indinavir
52
Which antiviral/class?: | Insulin resistance/DM
Protease Inhib ('-navir')
53
Which antiviral/class?: | injection site rxn
Enfuvirtide/ maraviroc
54
Which antiviral/class?: | restricted to CCR5 tropic virus
Maraviroc
55
Interferons: MOA Adverse (4)
Glycoproteins normally synthesized by virus-infected cells, exhibiting a wide range of ANTIVIRAL & ANTITUMOR properties (paracrine signaling) 1. Flu-like sump 2. depression 3. Neutropenia 4. Myopathy
56
``` Interferon-alpha: Clinical use (6) ```
1. Hep B/C 2. Kaposi (HHV8) 3. Condyloma acuminatum (HPV 6, 11) 4. Renal cell carcinoma 5. Hairy cell leukemia 6. Melanoma
57
Interferon-beta Clinical use | Interferone-gamma clinical use
IFN-B: MS IFN-g: CGD (by increasing phagocyte release of Superoxide species to improve microbicidal properties-->decrease risk by 70% of serious infections)
58
Ribavirin: MOA Clinical Uses (2) Adverse (2)
Competitively inhibiting Inosine Monophosphate Dehydrogenase--> inhib synthesis of Guanine Nucleotides 1. Chronic Hep C 2. RSV(2nd line) Adverse: 1. hemolytic anemia 2. severe teratogen
59
What is the preferred for treatment for RSV in children?
Palivizumab
60
Sofosbuvir: MOA Clinical Use (combo of...) Adverse (3)
Inhib HCV RNA-dep-RNA-pol acting as a chain terminator 1. chronic HCV in combo w/ Ribavirin, +/- Peg IFN-a (Never a Monotherapy) Adverse: 1. Fatigue 2. HA 3. N
61
Simeprevir: MOA Clinical Use (combo of...) Adverse (2)
HCV protease inhibitor--> stop viral replication 1. chronic HCV in combo w/ Ledipasvir (NS5A inhib) (Never a Monotherapy) Adverse: 1. Photosensitivity 2. Rash
62
Infection control techniques: describe Autoclave Sporicidal?
pressurized steam at >120C | possibly sporicidal
63
Infection control techniques: describe Alcohols and Chlorhexidine Sporicidal?
``` denature proteins and disrupt cell membranes NOT Sporicidal (will kill bacteria and viruses) ```
64
Infection control techniques: describe Hydrogen peroxide Sporicidal?
Free radical oxidation | SPORICIDAL
65
Infection control techniques: describe Iodine and Iodophors Sporicidal?
Halogenation of DNA, RNA, and proteins | possibly sporicidal
66
differentiate btw Disinfecting and Sterilizing?
Disinfect- decrease pathogens | Sterilizing- destroy living things
67
C.diff is a common cause of hospital infections. What is the best way to eliminate it?
C.diff is spore forming | ``` #1= hydrogen peroxide followed by autoclave/ iodine&iodophors ```
68
Antimicrobials to Avoid in Pregnancy: | 8 drugs
"SAFe Children Take Really Good Care" 1. Sulfonamides 2. Aminoglycosides 3. Fluroquinolones 4. Clarithromycin 5. Tetracyclines 6. Ribavirin 7. Griseofulvin 8. Chloramphenicol
69
Antimicrobials to Avoid in Pregnancy: | Kernicterus causing
sulfonamides
70
Antimicrobials to Avoid in Pregnancy: | ototoxicity causing
aminoglycosides
71
Antimicrobials to Avoid in Pregnancy: | cartilage damage
fluoroquinolones
72
Antimicrobials to Avoid in Pregnancy: | embryotoxic
clarithromycin
73
Antimicrobials to Avoid in Pregnancy: | discolored teeth, inhib of bone growth
tetracyclines
74
Antimicrobials to Avoid in Pregnancy: | teratogenic (2)
1. Ribavirin | 2. Griseofulvin
75
Antimicrobials to Avoid in Pregnancy: | Gray baby syndrome
Chloramphenicol
76
Drugs which inhibit IMP dehydrogenase (2)
1. Ribavirin (used to treat Hep C | 2. Mycophenolate (used to prevent organ transplant)
77
What is the triple therapy for Hep C?
1. Ribovirin 2. Simeprevir 3. Peg IFN-a